A Phase Ii Trial Of Durvalumab With Or Without Tremelimumab In Patients With Persistent Or Recurrent Endometrial Carcinoma And Endometrial Carcinosarcoma.Maria M Rubinstein,Imogen Caird,Qin Zhou,Alexia Iasonos,Claire Frances Friedman,Karen Anne Cadoo,Jason A. Konner,Roisin Eilish O'Cearbhaill,William P. Tew,Dmitriy Zamarin,Rachel N. Grisham,Chrisann Kyi,Krysten Soldan,Stuart M. Lichtman,Louise Ligresti,Sarah J. Schweber,Jasmeet Chadha Singh,Tiffany A. Troso-Sandoval,Carol Aghajanian,Vicky MakkerJOURNAL OF CLINICAL ONCOLOGY（2019）引用 26|浏览57暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
